The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...

I have a few questions about fluticasone-salmeterol. Is it true that the current guidelines call for dual therapy as opposed to monotherapy, ie, inhaled steroids? Also, if a child has recurrent use of ...

One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, ...

The classifications of severity are intermittent, mild-persistent, moderate-persistent, and severe-persistent (there is no longer a mild-intermittent classification). This change was made to emphasize ...

Please provide your email address to receive an email when new articles are posted on . Significantly fewer pediatric patients with low- vs. high-risk intermittent asthma had an ED visit and inhaled ...

Primatene Mist is the only OTC inhaler approved by the FDA for mild asthma in people 12 and older. Primatene Mist uses epinephrine, while albuterol uses albuterol sulfate, and they have different side ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AIRSUPRA’s US Prescribing Information now includes clinically meaningful evidence from the BATURA study in patients with mild asthma. 1 The BATURA Phase IIIb trial, ...

People with mild asthma may not need daily medicine to prevent flare-ups, as doctors now recommend. A study found that patients who take medicine only when asthma attacks occur fare about as well as ...

A single combined-drug inhaler used as needed protects adults with mild asthma from worsening illness and hospital stays, a recent commentary on Cochrane systematic review data reports. But long-term ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...